Home      About this journal      Authors      Referees      Editors      Readers      Archive      Contact us
Research progress review on ancient and modern clinical medication safety studies of Aconiti Lateralis Radix Praeparata
Hits 400  Download times 431  Received:February 18, 2025  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1673-9043.2025.06.12
Key Words   Aconiti Lateralis Radix Praeparata;Clinical application;Detoxification;Safety
Author NameAffiliationE-mail
LI Shuangqing Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
MAO Xinyu Clinical Pharmacology Research Center, The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300250, China  
XING Yongfa Clinical Pharmacology Research Center, The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300250, China  
ZHANG Li Clinical Pharmacology Research Center, The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300250, China tjgcp_zl@126.com 
WANG Baohe Binhai New Area Hospital of Traditional Chinese Medicine, Fourth Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300450, China  
Abstract
    The safety of Aconiti Lateralis Radix Praeparata(Fuzi) has long been a focal and challenging issue in clinical practice. Historically, medical practitioners have held divergent perspectives on its toxicity, and its misuse often leads to severe adverse outcomes. This study investigates the safety concerns of Fuzi in clinical application through a multidimensional approach, encompassing ancient textual records, clinical practical experience, analysis of toxic components, and strategies for enhancing efficacy and reducing toxicity. By systematically examining the inherent risks and toxicological profile of Fuzi, this research provides a comprehensive and detailed evaluation of its clinical applicability. Through rigorous scientific methods, the paper establishes a reference framework to guide clinicians in the safe and rational use of Fuzi, aiming to mitigate risks associated with improper administration and ensure medication safety.

You are the Guest visitor.

Copyright @ 2007
Address:   Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.